SCHEMBL751632

SCHEMBL751632

O=C1NC=N/C1=C\c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.50
METAP1 P53582 1/20 0.47
HPGD P15428 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
AKR1B1 P15121 2/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
APEX1 P27695 1/20 0.44
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MRE11 P49959 1/20 0.41
NAT1 P18440 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
APAF1 O14727 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714349 1.00 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL751633 1.00 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL3714215 0.78 MAPT (0.54) METAP1HPGDTDP1RAB9AALDH1A1
SCHEMBL3714214 0.78 MAPT (0.54) METAP1HPGDTDP1RAB9AALDH1A1
SCHEMBL132173 0.75 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL132172 0.75 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL3711176 0.75 LRRK2 (0.41)
Hydrogen Peroxide SCHEMBL29033947 0.74 GSK3B (0.49) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL29899807 0.72 CLK1 (0.54) GSK3BRAB9AMEN1KMT2AKDM4E
SCHEMBL3720355 0.71 IGF1R (0.51) HPGDTDP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130344591-A1 Modified Fluorescent Proteins and Methods for Using Same EVROGEN JSC (RU) 2013-12-26 US disclosed
US-8481307-B2 Modified fluorescent proteins and methods for using same EVROGEN JSC (RU) 2013-07-09 US disclosed
US-20120094377-A1 Modified Fluorescent Proteins and Methods for Using Same EVROGEN JSC (RU) 2012-04-19 US disclosed
EP-2430156-A1 MODIFIED FLUORESCENT PROTEINS AND METHODS FOR USING SAME Evrogen Jsc (RU) 2012-03-21 EP disclosed
US-7972834-B2 Modified fluorescent proteins and methods for using same Evrogen IP Joint Stock Company (RU) 2011-07-05 US disclosed
US-20110003974-A1 Modified fluorescent proteins and methods for using same Evrogen IP Joint Stock Company (RU) 2011-01-06 US disclosed
WO-2010131115-A1 MODIFIED FLUORESCENT PROTEINS AND METHODS FOR USING SAME EVROGEN JSC (RU) 2010-11-18 WO disclosed
WO-2010122426-A2 METHODS AND COMPOSITIONS FOR VISUALIZATION OF FLUORESCENT PROTEINS EVROGEN JSC (RU) 2010-10-28 WO disclosed